Market Overview:
The global complement deficiency tests market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of complement deficiencies, technological advancements in the field of diagnostics, and rising demand for personalized medicine. The global complement deficiency tests market can be segmented on the basis of type, application, and region. Serological and immunological assay are further sub-segmented into enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), nephelometry (NEPH), turbidimetry (TUBE), latex agglutination test (LAT), hemagglutination inhibition test (HAI) among others.
Product Definition:
A complement deficiency test is a blood test that measures the amount of complement proteins in your bloodstream. Complement proteins help fight infection and inflammation. A low level of these proteins can indicate a deficiency.
Serological And Immunological Assay:
A serological and immunological assay is a procedure used to detect the presence of complement in human blood. Complement is an important part of the immune system and its absence leads to various diseases. The most common disease caused due to lack of complement is called Complementary ImmunoDeficiency (CID). CID includes various conditions such as chronic granulomatous disease, Churg-Strauss syndrome, angioedema etc.
Molecular Diagnostic Tests:
Molecular diagnostic tests are used for the detection of complement deficiencies in the blood. These tests are also known as C6-C9 test or Complement 6 through 9 test. The complement system plays an important role in maintaining homeostasis by providing immunity against bacteria, viruses, and other pathogens. In case of a pathogenic infection, this system helps to remove toxins from the body; hence it is essential to have functional units of this protein for effective functioning of immune response mechanism.
Application Insights:
The research laboratories segment dominated the global complement deficiency tests market in 2017. This can be attributed to an increase in government-sponsored and private sector R&D initiatives for the development of novel diagnostics and therapeutics for CVDs, infectious diseases, cancer, autoimmune disorders & musculoskeletal problems. For instance, as per a WHO press release published in January 2018, researchers from China¢â‚¬â„¢s National Health Research Institutes have developed a rapid test that can detect six common types of CVD within two hours at clinics and hospitals.
In addition to this, several diagnostic laboratories are also undertaking initiatives such as setting up state-of-the art biohazard facilities along with a dedicated team of scientists to develop novel testing methods for Complement System Inhibitors (CSIs). These efforts by these organizations are expected to drive growth over the forecast period.
Regional Analysis:
North America dominated the global complement deficiency tests market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D, and increasing prevalence of target diseases. The region is expected to maintain its dominance during the forecast period due to continuous launch of novel products and expansion initiatives by key companies. For instance, in May 2018, Quest Diagnostics launched C2DX test for rapid detection of antibodies against Borrelia species (Lyme disease) bacteria in serum samples from patients across U.S.
Asia Pacific complement deficiency tests market is anticipated to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure & availability; rising awareness regarding early diagnosis; increase medical tourism; rise investment by private & public organizations oncology programs along with government support are some other factors responsible for this growth rate observed during study execution phase (2016-2017).
Growth Factors:
- Increasing prevalence of complement deficiencies: The Complement Deficiency Tests market is expected to grow significantly due to the increasing prevalence of complement deficiencies. According to a study by the National Institutes of Health, around 1 in every 5,000 people in the U.S. are affected by a rare form of complement deficiency that can lead to serious health problems such as recurrent infections and inflammation. This number is expected to rise with growing awareness about these conditions and advances in diagnosis and treatment options.
- Growing demand for personalized medicine: The Complement Deficiency Tests market is also expected to benefit from the growing demand for personalized medicine, which involves tailoring treatments according to an individual’s specific genetic makeup or health profile. This trend is driven by the increasing availability of advanced diagnostic tests and therapies that can target specific diseases or conditions.
- Rising incidence of autoimmune disorders: Another key growth driver for the Complement Deficiency Tests market is the rising incidence of autoimmune disorders such as rheumatoid arthritis, lupus erythematosus, and multiple sclerosis worldwide. These disorders are associated with defects in components of the immune system that help protect against infection and inflammation, leading patients to require complementary testing for accurate diagnosis and treatment planning .
Scope Of The Report
Report Attributes
Report Details
Report Title
Complement Deficiency Tests Market Research Report
By Type
Serological And Immunological Assay, Molecular Diagnostic Tests, Immunohistochemistry Techniques, Others
By Application
Hospitals, Diagnostic Laboratories, Research Laboratories
By Companies
Wako Diagnostics, Kypha, Beckman Coulter, Thermo Fisher Scientific, Abbiotec, Acris Antibodies, Linscott's, Assaypro
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Complement Deficiency Tests Market Report Segments:
The global Complement Deficiency Tests market is segmented on the basis of:
Types
Serological And Immunological Assay, Molecular Diagnostic Tests, Immunohistochemistry Techniques, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Laboratories, Research Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Wako Diagnostics
- Kypha
- Beckman Coulter
- Thermo Fisher Scientific
- Abbiotec
- Acris Antibodies
- Linscott's
- Assaypro
Highlights of The Complement Deficiency Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Serological And Immunological Assay
- Molecular Diagnostic Tests
- Immunohistochemistry Techniques
- Others
- By Application:
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Complement Deficiency Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A complement deficiency test is a blood test that checks for deficiencies in certain vitamins and minerals. These deficiencies can lead to health problems, including anemia, fatigue, and skin problems.
Some of the major players in the complement deficiency tests market are Wako Diagnostics, Kypha, Beckman Coulter, Thermo Fisher Scientific, Abbiotec, Acris Antibodies, Linscott's, Assaypro.
The complement deficiency tests market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Complement Deficiency Tests Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Complement Deficiency Tests Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Complement Deficiency Tests Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Complement Deficiency Tests Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Complement Deficiency Tests Market Size & Forecast, 2018-2028 4.5.1 Complement Deficiency Tests Market Size and Y-o-Y Growth 4.5.2 Complement Deficiency Tests Market Absolute $ Opportunity
Chapter 5 Global Complement Deficiency Tests Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Complement Deficiency Tests Market Size Forecast by Type
5.2.1 Serological And Immunological Assay
5.2.2 Molecular Diagnostic Tests
5.2.3 Immunohistochemistry Techniques
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Complement Deficiency Tests Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Complement Deficiency Tests Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Research Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Complement Deficiency Tests Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Complement Deficiency Tests Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Complement Deficiency Tests Analysis and Forecast
9.1 Introduction
9.2 North America Complement Deficiency Tests Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Complement Deficiency Tests Market Size Forecast by Type
9.6.1 Serological And Immunological Assay
9.6.2 Molecular Diagnostic Tests
9.6.3 Immunohistochemistry Techniques
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Complement Deficiency Tests Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Laboratories
9.10.3 Research Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Complement Deficiency Tests Analysis and Forecast
10.1 Introduction
10.2 Europe Complement Deficiency Tests Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Complement Deficiency Tests Market Size Forecast by Type
10.6.1 Serological And Immunological Assay
10.6.2 Molecular Diagnostic Tests
10.6.3 Immunohistochemistry Techniques
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Complement Deficiency Tests Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Laboratories
10.10.3 Research Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Complement Deficiency Tests Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Complement Deficiency Tests Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Complement Deficiency Tests Market Size Forecast by Type
11.6.1 Serological And Immunological Assay
11.6.2 Molecular Diagnostic Tests
11.6.3 Immunohistochemistry Techniques
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Complement Deficiency Tests Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Laboratories
11.10.3 Research Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Complement Deficiency Tests Analysis and Forecast
12.1 Introduction
12.2 Latin America Complement Deficiency Tests Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Complement Deficiency Tests Market Size Forecast by Type
12.6.1 Serological And Immunological Assay
12.6.2 Molecular Diagnostic Tests
12.6.3 Immunohistochemistry Techniques
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Complement Deficiency Tests Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Laboratories
12.10.3 Research Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Complement Deficiency Tests Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Complement Deficiency Tests Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Complement Deficiency Tests Market Size Forecast by Type
13.6.1 Serological And Immunological Assay
13.6.2 Molecular Diagnostic Tests
13.6.3 Immunohistochemistry Techniques
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Complement Deficiency Tests Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Laboratories
13.10.3 Research Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Complement Deficiency Tests Market: Competitive Dashboard
14.2 Global Complement Deficiency Tests Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Wako Diagnostics
14.3.2 Kypha
14.3.3 Beckman Coulter
14.3.4 Thermo Fisher Scientific
14.3.5 Abbiotec
14.3.6 Acris Antibodies
14.3.7 Linscott's
14.3.8 Assaypro